Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk prospective population study)

American Journal of Cardiology

Volumn 108, Issue 3, 2011, Pages 367-373

  Côté, Mélanie ^a,b   Cartier, Amélie ^a,b   Reuwer, Anne Q ^c   Arsenault, Benoit J ^a,c   Lemieux, Isabelle ^a   Després, Jean Pierre ^a,b   Wareham, Nicholas J ^d   Kastelein, John J P ^c   Boekholdt, S Matthijs ^c   Khaw, Kay Tee ^e  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIAS; KAPLAN-MEIER ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79960343983     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.053     Document Type: Article

References (24)

1. N. Day, S. Oakes, R. Luben, K.T. Khaw, S. Bingham, A. Welch, and N. Wareham EPIC-Norfolk: study design and characteristics of the cohort European Prospective Investigation of Cancer Br J Cancer 80 suppl 1 1999 95 103 (Pubitemid 29389613)
2. W.A. van der Steeg, S.M. Boekholdt, E.A. Stein, K. El-Harchaoui, E.S. Stroes, M.S. Sandhu, N.J. Wareham, J.W. Jukema, R. Luben, A.H. Zwinderman, J.J. Kastelein, and K.T. Khaw Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk Ann Intern Med 146 2007 640 648 (Pubitemid 351650519)
3. S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, and C. Lenfant Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 109 2004 433 438 (Pubitemid 38133916)
4. D. Rothenbacher, H. Brenner, W. Mrz, and W. Koenig Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers Eur Heart J 26 2005 1640 1646 (Pubitemid 41389695)
5. M. Cnop, P.J. Havel, K.M. Utzschneider, D.B. Carr, M.K. Sinha, E.J. Boyko, B.M. Retzlaff, R.H. Knopp, J.D. Brunzell, and S.E. Kahn Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469 (Pubitemid 36577787)
6. M. Cté, P. Maurige, J. Bergeron, N. Alméras, A. Tremblay, I. Lemieux, and J.P. Després Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men J Clin Endocrinol Metab 90 2005 1434 1439
7. B. Zietz, H. Herfarth, G. Paul, A. Ehling, U. Mller-Ladner, J. Schölmerich, and A. Schffler Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes FEBS Lett 545 2003 103 104 (Pubitemid 36694683)
8. G.A. Laughlin, E. Barrett-Connor, S. May, and C. Langenberg Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study Am J Epidemiol 165 2007 164 174 (Pubitemid 46096378)
9. J.G. Schneider, M. von Eynatten, S. Schiekofer, P.P. Nawroth, and K.A. Dugi Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo Diabetes Care 28 2005 2181 2186 (Pubitemid 41242465)
10. T.P. Combs, U.B. Pajvani, A.H. Berg, Y. Lin, L.A. Jelicks, M. Laplante, A.R. Nawrocki, M.W. Rajala, A.F. Parlow, L. Cheeseboro, Y.Y. Ding, R.G. Russell, D. Lindemann, A. Hartley, G.R. Baker, S. Obici, Y. Deshaies, M. Ludgate, L. Rossetti, and P.E. Scherer A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity Endocrinology 145 2004 367 383 (Pubitemid 38094532)
11. T. Yamauchi, J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, K. Murakami, T. Ohteki, S. Uchida, S. Takekawa, H. Waki, N.H. Tsuno, Y. Shibata, Y. Terauchi, P. Froguel, K. Tobe, S. Koyasu, K. Taira, T. Kitamura, T. Shimizu, R. Nagai, and T. Kadowaki Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769 (Pubitemid 36735700)
12. J.C. Fruchart Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism Am J Cardiol 88 suppl 2001 24N 29N
13. B. Vergs, J.M. Petit, L. Duvillard, G. Dautin, E. Florentin, F. Galland, and P. Gambert Adiponectin is an important determinant of apoA-I catabolism Arterioscler Thromb Vasc Biol 26 2006 1364 1369 (Pubitemid 44305383)
14. Y. Okamoto, S. Kihara, T. Funahashi, Y. Matsuzawa, and P. Libby Adiponectin: a key adipocytokine in metabolic syndrome Clin Sci (Lond) 110 2006 267 278 (Pubitemid 43341630)
15. N.L. Brooks, K.S. Moore, R.D. Clark, M.T. Perfetti, C.M. Trent, and T.P. Combs Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Diabetes Obes Metab 9 2007 246 258 (Pubitemid 46502042)
16. O.H. Franco, J.M. Massaro, J. Civil, M.R. Cobain, B. O'Malley, and R.B. D'Agostino Sr Trajectories of entering the metabolic syndrome: the Framingham Heart Study Circulation 120 2009 1943 1950
17. T. Pischon, C.J. Girman, G.S. Hotamisligil, N. Rifai, F.B. Hu, and E.B. Rimm Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737 (Pubitemid 38489895)
18. J.S. Rana, B.J. Arsenault, J.P. Despres, M. Cote, P.J. Talmud, E. Ninio, J.W. Jukema, N.J. Wareham, J.J. Kastelein, K.T. Khaw, and S.M. Boekholdt Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women Eur Heart J 32 2009 336 344
19. W. Koenig, N. Khuseyinova, J. Baumert, C. Meisinger, and H. Löwel Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany J Am Coll Cardiol 48 2006 1369 1377 (Pubitemid 44436825)
20. K. Hara, M. Horikoshi, T. Yamauchi, H. Yago, O. Miyazaki, H. Ebinuma, Y. Imai, R. Nagai, and T. Kadowaki Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 2006 1357 1362 (Pubitemid 44125935)
21. Y. Aso, R. Yamamoto, S. Wakabayashi, T. Uchida, K. Takayanagi, K. Takebayashi, T. Okuno, T. Inoue, K. Node, T. Tobe, T. Inukai, and Y. Nakano Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin Diabetes 55 2006 1954 1960 (Pubitemid 44509967)
22. T. Inoue, N. Kotooka, T. Morooka, H. Komoda, T. Uchida, Y. Aso, T. Inukai, T. Okuno, and K. Node High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease Am J Cardiol 100 2007 569 574 (Pubitemid 47223129)
23. N. Sattar, P. Watt, L. Cherry, S. Ebrahim, G. Davey Smith, and D.A. Lawlor High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective casecontrol study J Clin Endocrinol Metab 93 2008 1846 1849 (Pubitemid 351656528)
24. N. Komura, S. Kihara, M. Sonoda, M. Kumada, K. Fujita, A. Hiuge, T. Okada, Y. Nakagawa, S. Tamba, Y. Kuroda, N. Hayashi, S. Sumitsuji, T. Kawamoto, S. Matsumoto, N. Ouchi, Y. Arita, Y. Okamoto, I. Shimomura, T. Funahashi, and Y. Matsuzawa Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease Circ J 72 2008 23 28 (Pubitemid 351413321)